As many as 5.8 million Americans are currently living with Alzheimer's disease, a neurodegenerative condition associated with progressive cognitive decline, including loss of memory capabilities. Protein aggregates, composed ...
Sep 7, 2023
0
48
Alzheimer's disease is the most common cause of dementia that affects more than 6.5 million Americans, according to the Alzheimer's Association. To find effective treatments and slow the progression of this debilitating disease, ...
Sep 7, 2023
0
52
Losing the activity of a key ion channel in the brain may contribute to the buildup of a devastating and toxic protein responsible for the clumps of plaque that accumulate in Alzheimer's disease, a team of neurobiologists ...
The passing of June's summer solstice, the longest day of the year, prompts reflection on all of the ways people work to shine a light in the darkness. June is also Alzheimer's Awareness Month, a time in which we strive to ...
Jul 31, 2023
0
36
A second Alzheimer's drug proven to slow cognitive decline was a step closer to US approval on Monday after clinical trial results published in a top journal confirmed its efficacy.
Jul 22, 2023
0
9
Two pathologies drive the progression of Alzheimer's disease. Early on, amyloid beta plaques lead the way, but around the time cognitive symptoms arise, tau tangles take over as the driving force and cognition steadily declines. ...
Jul 13, 2023
0
93
Now that the emergency phase of the COVID-19 pandemic has ended, scientists are looking at ways to surveil indoor environments in real time for viruses. By combining recent advances in aerosol sampling technology and an ultrasensitive ...
Jul 10, 2023
0
126
The US drug regulator gave full approval to a new Alzheimer's medicine on Thursday, a move that makes it more widely available to the public through government-run health insurance for the elderly.
Jul 7, 2023
0
3
Recent research from the Tanz Center for Research in Neurodegenerative Diseases in the University of Toronto's Temerty Faculty of Medicine is challenging long-held views of how a hormone called somatostatin influences the ...
Jul 5, 2023
0
83
When Daniel Gibbs, M.D., enrolled in an Alzheimer's study at UC San Francisco almost a decade ago, researchers needed access to a secure government facility just to confirm that he had the disease. They summoned Gibbs to ...
Jun 30, 2023
0
20
